MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc. Common Stock (CCCC)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Symbol
CCCC
Shares outstanding
70.9M shares
Disclosed Ownership
4.75M shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Filing time
07 Aug 2025, 12:50:20 UTC
Date of event
30 Jun 2025
Previous filing
03 Feb 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 6.7% 4.75M 0 4.75M Christopher O'Hara Authorized Signatory, Morgan Stanley